2592 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Cloudbreak Pharma, Inc. is an investment holding company, which engages in the research and development of therapeutic biologics. Its pipeline includes CBT-001, CBT-009, CBT-004, CBT-006, CBT-199, CBT-145, CBT-007, and CBT-011. The company was founded by Jin Song Ni, Van Son Dinh, and Jun Zhi Li in September 2015 and is headquartered in Irvine, CA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
2592 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company